
Results
2
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
2 companies
Revenio Group Oyj
Market Cap: €662.4m
Provides ophthalmological devices and software solutions for the diagnosis of glaucoma, macular degeneration, and diabetic retinopathy in Finland, the United States, and internationally.
REG1V
€24.90
7D
3.5%
1Y
-21.5%
Nexstim
Market Cap: €101.0m
A medical technology company, engages in the development of non-invasive brain stimulation technologies in Finland, rest of Europe, North America, and internationally.
NXTMH
€14.00
7D
-7.0%
1Y
165.2%